Skip to main content

3 Result(s)

within English Remove this filter Medicine & Public Health Remove this filter Cancer Research Remove this filter Intensive / Critical Care Medicine Remove this filter Oncology Remove this filter S. Rule Remove this filter Article Remove this filter

and

  1. Article

    Open Access

    Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

    We report follow-up results from the randomized, placebo-controlled, phase 3 HELIOS trial of ibrutinib+bendamustine and rituximab (BR) for previously treated chronic lymphocytic leukemia (CLL)/small lymphocyti...

    G. Fraser, P. Cramer, F. Demirkan, R. Santucci Silva, S. Grosicki, A. Pristupa… in Leukemia (2019)

    Download PDF (714 KB) View Article

  2. Article

    Open Access

    Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, F Offner, D Caballero… in Leukemia (2018)

    Download PDF (668 KB) View Article

  3. No Access

    Article

    The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma

    The role of both autologous (autoSCT) and allogeneic stem cell transplantation (alloSCT) in the management of mantle cell lymphoma (MCL) remains to be clarified. We conducted a consensus project using the RAND...

    S Robinson, P Dreger, D Caballero, P Corradini, C Geisler, M Ghielmini… in Leukemia (2015)